By apyxmedical In 2022 Shareholder News, 2023 Shareholder News, J-Plasma, RenuvionPosted January 10, 2023APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 REVENUE RESULTS READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted November 22, 2022APYX MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER SANDLER 34TH ANNUAL HEALTHCARE CONFERENCE READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted November 10, 2022APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND UPDATES FULL YEAR 2022 FINANCIAL OUTLOOK READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted September 26, 2022APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS ON NOVEMBER 10, 2022 READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted September 13, 2022‘BOTCHED’ TV STAR DR. PAUL NASSIF AMONG TOP U.S. PLASTIC SURGEONS USING RENUVION HELIUM PLASMA TECHNOLOGY IN COSMETIC PROCEDURES READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted September 6, 2022APYX MEDICAL CORPORATION TO PARTICIPATE IN THE LAKE STREET BEST IDEAS GROWTH CONFERENCE READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted August 11, 2022APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND UPDATES FULL YEAR 2022 FINANCIAL OUTLOOK READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 27, 2022APYX MEDICAL CORPORATION RELEASES ENVIRONMENTAL, SOCIAL AND GOVERNANCE DATA IN NEW TEAR SHEET READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 18, 2022RENUVION CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECK READ MORE
By apyxmedical In 2022 Shareholder News, J-Plasma, RenuvionPosted July 18, 2022APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO IMPROVE APPEARANCE OF LAX (LOOSE) SKIN READ MORE
